Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.878
+0.043 (5.16%)
At close: Dec 20, 2024, 4:00 PM
0.841
-0.037 (-4.27%)
After-hours: Dec 20, 2024, 5:53 PM EST
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$24,034
Profits / Employee
-$1,261,145
Market Cap
3.94M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Mainz Biomed | 71 |
| Galmed Pharmaceuticals | 8 |
| Autonomix Medical | 8 |
| Channel Therapeutics | 8 |
| Synaptogenix | 5 |
| Protagenic Therapeutics | 3 |
| Aptorum Group | 3 |
| GT Biopharma | 2 |
SILO News
- 3 days ago - Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia - GlobeNewsWire
- 22 days ago - Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management - GlobeNewsWire
- 4 weeks ago - Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders - GlobeNewsWire
- 7 weeks ago - Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant - GlobeNewsWire
- 3 months ago - Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD - GlobeNewsWire
- 4 months ago - Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic - GlobeNewsWire
- 4 months ago - Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide - GlobeNewsWire
- 5 months ago - Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference - GlobeNewsWire